Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.3 trillion and total revenue of $115.83 billion.
Market Cap
1.3T
Revenue
115.83B
Profits
-36.07B
PE Ratio
n/a
Profit Margin
-31.14%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 133.74B | 0.28% | 817,154 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 78.76B | -0.80% | 13,298,631 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 75.12B | -4.54% | 1,065,207 | 15.53B |
| 4 | ARGX | argenx SE | 60.06B | 1.33% | 264,655 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 43.24B | -1.58% | 1,813,908 | - |
| 6 | ONC | BeOne Medicines AG | 41.73B | 1.70% | 349,661 | 6.13B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.17B | -0.23% | 1,113,441 | 4.80B |
| 8 | RPRX | Royalty Pharma plc | 33.56B | 0.27% | 1,862,609 | 2.54B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.71B | 3.30% | 6,970,692 | 7.53M |
| 10 | INSM | Insmed Incorporated | 25.70B | -0.14% | 1,530,686 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.30B | 0.75% | 1,429,371 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.89B | 0.57% | 681,817 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.92B | 0.11% | 2,794,568 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.47B | 0.14% | 792,458 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 15.11B | 1.97% | 747,504 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.46B | 0.36% | 1,277,291 | 2.44B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.02B | 1.59% | 2,945,960 | 713.07M |
| 18 | HALO | Halozyme Therapeutics, Inc. | 12.81B | -0.89% | 2,236,701 | 1.66B |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.49B | -0.49% | 1,140,907 | 830.81M |
| 20 | SMMT | Summit Therapeutics Inc. | 12.35B | -0.83% | 5,704,748 | - |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.96B | 0.22% | 333,319 | 1.28B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 11.51B | -1.33% | 2,357,960 | 3.41B |
| 23 | TECH | Bio-Techne Corporation | 11.37B | -0.14% | 3,633,631 | 1.22B |
| 24 | TWST | Twist Bioscience Corporation | 11.26B | -1.77% | 2,196,599 | 431.80M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 10.15B | -0.64% | 707,385 | 776.57M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.98B | -2.53% | 298,919 | 440.48M |
| 27 | KYMR | Kymera Therapeutics, Inc. | 9.31B | 0.04% | 723,650 | 105.00M |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.25B | -0.70% | 1,502,962 | 669.50M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 9.23B | 0.51% | 925,456 | 281.99M |
| 30 | CYTK | Cytokinetics, Incorporated | 9.20B | 2.32% | 2,545,194 | 67.67M |
| 31 | IBRX | ImmunityBio, Inc. | 9.03B | 0.95% | 10,395,444 | 165.79M |
| 32 | CAI | Caris Life Sciences, Inc. | 8.97B | -0.72% | 3,916,205 | 989.61M |
| 33 | PCVX | Vaxcyte, Inc. | 8.67B | 3.66% | 1,848,868 | - |
| 34 | ABVX | ABIVAX Société Anonyme | 8.31B | 6.36% | 1,680,193 | 5.33M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 7.98B | 1.73% | 436,720 | 7.46M |
| 36 | TGTX | TG Therapeutics, Inc. | 7.97B | -2.16% | 1,442,332 | 799.54M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.57B | 2.40% | 3,563,429 | 874.09M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 7.56B | 0.12% | 1,045,375 | - |
| 39 | IMVT | Immunovant, Inc. | 6.92B | 0.57% | 1,229,297 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.79B | -0.10% | 840,582 | 239.92M |
| 41 | BLTE | Belite Bio, Inc | 6.68B | -0.86% | 114,228 | - |
| 42 | LGND | Ligand Pharmaceuticals Incorporated | 6.26B | 4.17% | 239,586 | 290.54M |
| 43 | CGON | CG Oncology, Inc. | 6.17B | 3.66% | 1,749,224 | 6.23M |
| 44 | SRRK | Scholar Rock Holding Corporation | 5.98B | 1.03% | 1,569,478 | - |
| 45 | TVTX | Travere Therapeutics, Inc. | 5.80B | 3.58% | 1,234,787 | 591.33M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 5.71B | -1.94% | 1,268,362 | 618.07M |
| 47 | KOD | Kodiak Sciences Inc. | 5.64B | 177.96% | 38,470,314 | - |
| 48 | ORKA | Oruka Therapeutics, Inc. | 5.57B | -0.32% | 917,720 | - |
| 49 | COGT | Cogent Biosciences, Inc. | 5.53B | -1.39% | 2,208,424 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.50B | 5.23% | 1,913,786 | 1.01B |
| 51 | CRSP | CRISPR Therapeutics AG | 5.23B | -0.26% | 1,266,218 | 13.39M |
| 52 | DFTX | Definium Therapeutics, Inc. | 5.16B | 6.19% | 2,986,797 | - |
| 53 | IOVA | Iovance Biotherapeutics, Inc. | 4.98B | -0.09% | 12,217,437 | 324.97M |
| 54 | ERAS | Erasca, Inc. | 4.94B | -0.84% | 3,574,027 | - |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.91B | -0.81% | 643,447 | 1.90M |
| 56 | MANE | Veradermics, Incorporated | 4.80B | -1.35% | 633,451 | - |
| 57 | ABCL | AbCellera Biologics Inc. | 4.51B | 9.61% | 6,973,097 | 66.17M |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.32B | 1.14% | 2,623,664 | - |
| 59 | TNGX | Tango Therapeutics, Inc. | 4.10B | -2.49% | 2,413,325 | 53.81M |
| 60 | PBLS | Parabilis Medicines, Inc. | 4.02B | 4.39% | 807,546 | 148.00K |
| 61 | CELC | Celcuity Inc. | 3.90B | 0.15% | 558,383 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 3.88B | 1.26% | 1,843,537 | 10.35M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.85B | -7.11% | 8,556,192 | - |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.84B | 1.48% | 850,089 | 890.79M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.69B | 4.18% | 1,053,699 | 234.13M |
| 66 | LEGN | Legend Biotech Corporation | 3.61B | -2.56% | 1,543,881 | 1.27B |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.56B | -0.60% | 2,515,669 | 7.50M |
| 68 | ACAD | Acadia Pharmaceuticals Inc. | 3.54B | -0.73% | 3,434,544 | 1.14B |
| 69 | ARQT | Arcutis Biotherapeutics, Inc. | 3.44B | 1.52% | 2,511,294 | 463.98M |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.37B | 2.82% | 1,281,216 | - |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 3.37B | 1.48% | 920,004 | 606.33M |
| 72 | DNLI | Denali Therapeutics Inc. | 3.35B | 2.89% | 2,554,384 | 3.60M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.18B | 0.16% | 1,249,279 | 117.00M |
| 74 | DYN | Dyne Therapeutics, Inc. | 3.05B | 1.93% | 2,302,069 | - |
| 75 | ZLAB | Zai Lab Limited | 2.88B | 2.84% | 883,699 | 449.61M |
| 76 | NAMS | NewAmsterdam Pharma Company N.V. | 2.82B | 4.43% | 2,044,394 | 7.12M |
| 77 | PGEN | Precigen, Inc. | 2.80B | 0.77% | 3,488,954 | 85.72M |
| 78 | MBX | MBX Biosciences, Inc. | 2.77B | 7.29% | 438,788 | - |
| 79 | QURE | uniQure N.V. | 2.71B | 2.30% | 1,372,895 | 18.67M |
| 80 | GPCR | Structure Therapeutics Inc. | 2.50B | -2.41% | 728,317 | - |
| 81 | IRON | Disc Medicine, Inc. | 2.49B | -0.49% | 480,547 | - |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.47B | 1.25% | 1,821,803 | 158.00K |
| 83 | IMNM | Immunome, Inc. | 2.46B | 1.26% | 945,208 | 4.02M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.46B | 2.87% | 1,672,962 | 36.77M |
| 85 | BEAM | Beam Therapeutics Inc. | 2.42B | -0.16% | 1,273,617 | 156.04M |
| 86 | VERA | Vera Therapeutics, Inc. | 2.34B | -0.12% | 1,464,641 | - |
| 87 | SLS | SELLAS Life Sciences Group, Inc. | 2.34B | -0.17% | 3,751,570 | - |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 2.33B | -2.98% | 782,226 | 959.90M |
| 89 | VRDN | Viridian Therapeutics, Inc. | 2.33B | 0.49% | 1,339,050 | 71.13M |
| 90 | ADMA | ADMA Biologics, Inc. | 2.27B | 7.89% | 3,567,999 | 512.28M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | -0.89% | 1,692,951 | - |
| 92 | PHVS | Pharvaris N.V. | 2.24B | -0.34% | 753,250 | - |
| 93 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | 0.49% | 626,238 | 311.51M |
| 94 | ADRX | ADARx Pharmaceuticals, Inc. | 2.15B | 3.82% | 1,205,156 | 6.13M |
| 95 | NKTR | Nektar Therapeutics | 2.06B | 5.85% | 1,255,825 | 54.59M |
| 96 | VCEL | Vericel Corporation | 2.06B | 1.33% | 643,083 | 306.30M |
| 97 | TRVI | Trevi Therapeutics, Inc. | 2.05B | -0.14% | 1,613,730 | - |
| 98 | PVLA | Palvella Therapeutics, Inc. | 2.01B | 1.21% | 188,513 | - |
| 99 | BHVN | Biohaven Ltd. | 2.00B | 2.16% | 2,045,966 | - |
| 100 | URGN | UroGen Pharma Ltd. | 2.00B | -1.09% | 1,149,082 | 188.73M |
| 101 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | 2.58% | 861,093 | 98.34M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.99B | 0.70% | 2,266,024 | 1.97B |
| 103 | RXRX | Recursion Pharmaceuticals, Inc. | 1.98B | -1.07% | 12,836,882 | 54.86M |
| 104 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.98B | 0.39% | 1,409,255 | 208.78M |
| 105 | NUVB | Nuvation Bio Inc. | 1.97B | -2.44% | 4,584,479 | 169.90M |
| 106 | ZYME | Zymeworks Inc. | 1.92B | 2.26% | 638,708 | 37.13M |
| 107 | LKFT | Lakefront Biotherapeutics NV | 1.92B | 1.57% | 206,616 | 1.13B |
| 108 | GENB | Generate Biomedicines, Inc. | 1.91B | -1.58% | 1,045,545 | 26.48M |
| 109 | FTRE | Fortrea Holdings Inc. | 1.91B | 0.85% | 1,339,147 | 2.68B |
| 110 | XNCR | Xencor, Inc. | 1.90B | 7.56% | 1,532,211 | 104.97M |
| 111 | MESO | Mesoblast Limited | 1.86B | -4.10% | 235,817 | 120.25M |
| 112 | SEPN | Septerna, Inc. | 1.85B | 5.22% | 338,235 | 98.88M |
| 113 | ZBIO | Zenas BioPharma, Inc. | 1.80B | 2.23% | 615,327 | 1.00M |
| 114 | NVAX | Novavax, Inc. | 1.78B | 1.60% | 4,448,293 | 413.80M |
| 115 | VIR | Vir Biotechnology, Inc. | 1.78B | -1.41% | 1,369,925 | 303.23M |
| 116 | OCUL | Ocular Therapeutix, Inc. | 1.68B | -20.67% | 15,411,592 | 52.06M |
| 117 | STOK | Stoke Therapeutics, Inc. | 1.65B | 2.82% | 835,003 | 27.59M |
| 118 | ABSI | Absci Corporation | 1.63B | -2.57% | 2,932,778 | 1.56M |
| 119 | TSHA | Taysha Gene Therapies, Inc. | 1.63B | 6.85% | 4,869,918 | 5.49M |
| 120 | NBTX | Nanobiotix S.A. | 1.61B | -0.63% | 49,162 | 13.15M |
| 121 | GHRS | GH Research PLC | 1.61B | -1.76% | 609,636 | - |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.60B | -1.39% | 552,287 | 20.00M |
| 123 | NTLA | Intellia Therapeutics, Inc. | 1.60B | -2.81% | 3,253,205 | 59.51M |
| 124 | SNDX | Syndax Pharmaceuticals, Inc. | 1.59B | -1.87% | 1,554,138 | 252.25M |
| 125 | IMCR | Immunocore Holdings plc | 1.58B | -0.16% | 266,622 | 430.78M |
| 126 | COAG | Hemab Therapeutics Holdings, Inc. | 1.55B | -4.66% | 348,326 | - |
| 127 | INVA | Innoviva, Inc. | 1.53B | 2.36% | 614,973 | 440.00M |
| 128 | ANAB | AnaptysBio, Inc. | 1.52B | -0.39% | 412,638 | 106.09M |
| 129 | INBX | Inhibrx Biosciences, Inc. | 1.50B | 2.11% | 188,144 | 1.30M |
| 130 | MAZE | Maze Therapeutics, Inc. | 1.49B | 3.19% | 1,175,949 | 20.00M |
| 131 | TYRA | Tyra Biosciences, Inc. | 1.47B | -1.42% | 824,580 | - |
| 132 | AVBP | ArriVent BioPharma, Inc. | 1.44B | 2.99% | 1,016,619 | - |
| 133 | KLRA | Kailera Therapeutics, Inc. | 1.44B | -0.85% | 1,244,720 | - |
| 134 | RARE | Ultragenyx Pharmaceutical Inc. | 1.42B | -0.62% | 4,896,240 | 717.00M |
| 135 | OMER | Omeros Corporation | 1.41B | -3.24% | 988,627 | 38.42M |
| 136 | KRSA | Korsana Biosciences, Inc. | 1.40B | -0.55% | 51,478 | - |
| 137 | DRTS | Alpha Tau Medical Ltd. | 1.39B | 3.44% | 342,018 | - |
| 138 | KARD | Kardigan, Inc. | 1.38B | 0.14% | 364,854 | - |
| 139 | AAPG | Ascentage Pharma Group International | 1.38B | 0.23% | 4,271 | 94.61M |
| 140 | BRVE | Braveheart Bio, Inc. | 1.38B | 2.18% | 389,235 | - |
| 141 | ORIC | ORIC Pharmaceuticals, Inc. | 1.38B | 0.84% | 1,514,741 | - |
| 142 | TRAX | First Tracks Biotherapeutics, Inc. | 1.31B | 6.46% | 674,495 | - |
| 143 | SVRA | Savara Inc. | 1.29B | 1.40% | 4,370,964 | - |
| 144 | DMRA | Damora Therapeutics, Inc. | 1.28B | 0.44% | 513,622 | - |
| 145 | AVLN | Avalyn Pharma Inc. | 1.26B | 0.96% | 205,865 | - |
| 146 | BCAX | Bicara Therapeutics Inc. | 1.24B | -2.13% | 775,255 | - |
| 147 | LBRX | LB Pharmaceuticals Inc | 1.22B | 1.50% | 534,572 | - |
| 148 | REPL | Replimune Group, Inc. | 1.18B | 1.62% | 1,966,351 | - |
| 149 | IMTX | Immatics N.V. | 1.16B | 1.55% | 1,408,522 | 47.65M |
| 150 | LTGO | Latigo Biotherapeutics, Inc. | 1.16B | 1.92% | 259,979 | - |
| 151 | SLBT | SL Science Holding Limited | 1.10B | 22.93% | 274,112 | 3.27M |
| 152 | VOR | Vor Biopharma Inc. | 1.08B | -1.13% | 930,084 | - |
| 153 | MNKD | MannKind Corporation | 1.08B | 0.30% | 2,072,168 | 393.63M |
| 154 | AKTS | Aktis Oncology, Inc. | 1.08B | -0.41% | 223,198 | 10.06M |
| 155 | MGTX | MeiraGTx Holdings plc | 1.07B | 1.83% | 922,382 | 397.50M |
| 156 | SPTX | Seaport Therapeutics, Inc. | 1.05B | -8.92% | 284,474 | - |
| 157 | ANRO | Alto Neuroscience, Inc. | 1.05B | 0.64% | 586,993 | - |
| 158 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | 4.68% | 212,720 | 99.00K |
| 159 | JANX | Janux Therapeutics, Inc. | 1.01B | 1.72% | 473,047 | 24.00M |
| 160 | GLUE | Monte Rosa Therapeutics, Inc. | 999.02M | -0.51% | 524,808 | 28.73M |
| 161 | CRVS | Corvus Pharmaceuticals, Inc. | 998.52M | 2.15% | 1,206,439 | - |
| 162 | ANL | Adlai Nortye Group Ltd. | 991.73M | -0.84% | 63,504 | 18.06M |
| 163 | MLTX | MoonLake Immunotherapeutics | 983.83M | -3.99% | 1,519,292 | - |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 962.10M | 0.95% | 1,106,957 | - |
| 165 | ABUS | Arbutus Biopharma Corporation | 959.56M | 0.21% | 10,585,759 | 181.72M |
| 166 | KURA | Kura Oncology, Inc. | 943.87M | -1.39% | 1,577,065 | 77.23M |
| 167 | ALMS | Alumis Inc. | 926.76M | 0.85% | 2,244,680 | 7.40M |
| 168 | RIGL | Rigel Pharmaceuticals, Inc. | 922.04M | 2.45% | 180,832 | 276.79M |
| 169 | HELP | Cybin Inc. | 919.83M | -0.16% | 985,865 | - |
| 170 | JBIO | Jade Biosciences, Inc. | 912.62M | -0.49% | 598,627 | - |
| 171 | APMD | Apnimed, Inc. | 902.14M | 2.75% | 283,762 | 115.12M |
| 172 | SANA | Sana Biotechnology, Inc. | 877.13M | -0.51% | 1,973,633 | - |
| 173 | SGP | SpyGlass Pharma, Inc. | 868.98M | -4.03% | 119,998 | - |
| 174 | CADL | Candel Therapeutics, Inc. | 856.24M | 1.54% | 664,720 | - |
| 175 | ARDX | Ardelyx, Inc. | 849.73M | -0.29% | 3,318,020 | 450.89M |
| 176 | LXRX | Lexicon Pharmaceuticals, Inc. | 845.42M | 5.85% | 10,886,412 | 41.47M |
| 177 | OBX | Obsidian Therapeutics, Inc. | 825.90M | 3.97% | 912,852 | - |
| 178 | IMMX | Immix Biopharma, Inc. | 820.56M | 4.56% | 995,598 | - |
| 179 | AVTX | Avalo Therapeutics, Inc. | 808.74M | -2.52% | 749,612 | 59.00K |
| 180 | ATTO | Attovia Therapeutics, Inc. | 805.74M | -0.73% | 403,017 | 1.80M |
| 181 | FDMT | 4D Molecular Therapeutics, Inc. | 804.36M | 0.62% | 1,555,415 | 92.01M |
| 182 | GERN | Geron Corporation | 803.09M | -0.79% | 5,620,924 | 204.56M |
| 183 | ACRS | Aclaris Therapeutics, Inc. | 799.29M | 5.44% | 2,429,059 | 8.22M |
| 184 | ACHV | Achieve Life Sciences, Inc. | 797.49M | 2.79% | 1,301,094 | - |
| 185 | GYRE | Gyre Therapeutics, Inc. | 795.25M | 2.04% | 137,048 | 109.82M |
| 186 | IVA | Inventiva S.A. | 793.87M | 4.75% | 3,418,745 | 2.81M |
| 187 | SLDB | Solid Biosciences Inc. | 780.60M | -0.14% | 1,413,498 | - |
| 188 | DSGN | Design Therapeutics, Inc. | 773.51M | 1.98% | 432,937 | - |
| 189 | ANNX | Annexon, Inc. | 760.21M | 10.16% | 5,072,575 | - |
| 190 | OLMA | Olema Pharmaceuticals, Inc. | 753.35M | -1.60% | 978,169 | - |
| 191 | PHAR | Pharming Group N.V. | 740.37M | 0.57% | 15,276 | 366.48M |
| 192 | WVE | Wave Life Sciences, Inc. | 723.17M | -2.91% | 3,531,950 | 65.37M |
| 193 | FTH | Faeth Therapeutics, Inc. | 717.59M | -0.82% | 195,465 | - |
| 194 | ETRA | Electra Therapeutics, Inc. | 710.52M | -1.99% | 536,017 | - |
| 195 | DNA | Ginkgo Bioworks Holdings, Inc. | 704.38M | -1.88% | 2,120,909 | 132.42M |
| 196 | VSTM | Verastem, Inc. | 703.68M | 0.39% | 1,260,318 | 87.53M |
| 197 | DBVT | DBV Technologies S.A. | 697.14M | 0.69% | 711,345 | 5.04M |
| 198 | OABI | OmniAb, Inc. | 689.15M | 2.82% | 674,446 | 38.46M |
| 199 | MDXG | MiMedx Group, Inc. | 682.89M | 0.32% | 875,733 | 355.17M |
| 200 | BLSM | BlossomHill Therapeutics, Inc. | 678.29M | 8.05% | 146,347 | - |
| 201 | NVCT | Nuvectis Pharma, Inc. | 678.02M | 2.92% | 137,697 | - |
| 202 | SLN | Silence Therapeutics plc | 674.34M | 0.18% | 710,710 | 615.00K |
| 203 | CLYM | Climb Bio, Inc. | 674.30M | 0.69% | 802,859 | - |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 671.04M | 2.36% | 742,484 | 136.07M |
| 205 | STTK | Shattuck Labs, Inc. | 645.34M | 5.93% | 976,889 | 1.00M |
| 206 | AURA | Aura Biosciences, Inc. | 637.78M | 2.50% | 483,632 | - |
| 207 | CBIO | Crescent Biopharma, Inc. | 621.90M | 3.86% | 228,623 | 11.88M |
| 208 | SGMT | Sagimet Biosciences Inc. | 617.86M | 7.58% | 1,345,215 | - |
| 209 | CRMD | CorMedix Inc. | 614.98M | 0.51% | 481,891 | 462.25M |
| 210 | VALN | Valneva SE | 597.30M | 5.37% | 21,569 | 163.30M |
| 211 | CTMX | CytomX Therapeutics, Inc. | 586.15M | -0.37% | 2,689,123 | 18.30M |
| 212 | PHAT | Phathom Pharmaceuticals, Inc. | 583.81M | 0.68% | 1,690,906 | 239.66M |
| 213 | MPLT | MapLight Therapeutics, Inc. | 580.77M | -0.10% | 251,080 | - |
| 214 | ALT | Altimmune, Inc. | 575.77M | -3.27% | 3,357,480 | 31.00K |
| 215 | NGNE | Neurogene Inc. | 569.92M | 0.60% | 174,821 | 925.00K |
| 216 | ALLO | Allogene Therapeutics, Inc. | 563.15M | -1.21% | 5,025,609 | 4.64M |
| 217 | MNPR | Monopar Therapeutics Inc. | 561.94M | -1.78% | 268,011 | - |
| 218 | OCS | Oculis Holding AG | 559.29M | -2.27% | 266,617 | 1.45M |
| 219 | EPRX | Eupraxia Pharmaceuticals Inc. | 527.23M | 2.50% | 368,724 | - |
| 220 | DRUG | Bright Minds Biosciences Inc. | 515.74M | -0.58% | 91,672 | - |
| 221 | PRME | Prime Medicine, Inc. | 511.47M | -0.86% | 3,681,150 | 4.07M |
| 222 | PBYI | Puma Biotechnology, Inc. | 506.91M | 0.51% | 245,648 | 231.24M |
| 223 | CAPR | Capricor Therapeutics, Inc. | 506.39M | 4.19% | 1,846,899 | 11.13M |
| 224 | YDES | YD Bio Limited | 503.61M | 24.08% | 507,538 | 1.24M |
| 225 | AGMB | AgomAb Therapeutics NV | 502.82M | -2.85% | 147,155 | - |
| 226 | AUTL | Autolus Therapeutics plc | 495.06M | 0.27% | 1,399,624 | 117.39M |
| 227 | RGNX | REGENXBIO Inc. | 493.12M | 0.95% | 1,237,529 | 174.48M |
| 228 | ARVN | Arvinas, Inc. | 491.05M | -1.05% | 512,058 | 316.70M |
| 229 | PROK | ProKidney Corp. | 486.74M | 0.63% | 1,814,502 | 818.00K |
| 230 | CTNM | Contineum Therapeutics, Inc. | 480.80M | 1.75% | 532,341 | - |
| 231 | ASMB | Assembly Biosciences, Inc. | 480.71M | -0.25% | 117,453 | 74.85M |
| 232 | OVID | Ovid Therapeutics Inc. | 480.43M | 2.50% | 1,190,689 | 1.58M |
| 233 | ENTX | Entera Bio Ltd. | 465.75M | -2.00% | 340,526 | 42.00K |
| 234 | TECX | Tectonic Therapeutic, Inc. | 459.61M | -0.68% | 234,833 | - |
| 235 | DMAC | DiaMedica Therapeutics Inc. | 448.66M | 4.79% | 362,389 | - |
| 236 | PRTA | Prothena Corporation plc | 448.43M | 5.37% | 488,855 | 54.53M |
| 237 | RZLT | Rezolute, Inc. | 438.47M | 7.18% | 1,587,527 | - |
| 238 | INDP | Indaptus Therapeutics, Inc. | 438.37M | -14.55% | 584,182 | - |
| 239 | EIKN | Eikon Therapeutics, Inc. | 428.99M | - | 434,150 | - |
| 240 | AGEN | Agenus Inc. | 424.54M | 10.42% | 2,763,997 | 132.69M |
| 241 | KYTX | Kyverna Therapeutics, Inc. | 421.77M | 0.15% | 996,963 | - |
| 242 | IRD | Opus Genetics, Inc. | 420.14M | 6.09% | 1,161,281 | 9.86M |
| 243 | AVIR | Atea Pharmaceuticals, Inc. | 418.27M | 0.87% | 238,372 | - |
| 244 | SCTX | Scribe Therapeutics Inc. | 412.14M | 2.30% | 306,902 | 33.30M |
| 245 | SPRY | ARS Pharmaceuticals, Inc. | 411.21M | 1.35% | 949,829 | 116.93M |
| 246 | ARCT | Arcturus Therapeutics Holdings Inc. | 411.00M | 4.40% | 824,601 | 29.37M |
| 247 | RLMD | Relmada Therapeutics, Inc. | 404.28M | -1.04% | 986,514 | - |
| 248 | PRLD | Prelude Therapeutics Incorporated | 402.71M | 0.90% | 496,150 | 22.42M |
| 249 | GALT | Galectin Therapeutics Inc. | 396.34M | 0.77% | 168,738 | - |
| 250 | ZURA | Zura Bio Limited | 392.90M | 1.49% | 1,465,028 | - |
| 251 | TTRX | Turn Therapeutics Inc. | 388.44M | 4.40% | 76,721 | - |
| 252 | EDIT | Editas Medicine, Inc. | 385.49M | -2.71% | 2,202,019 | 47.01M |
| 253 | FENC | Fennec Pharmaceuticals Inc. | 383.99M | 3.25% | 210,217 | 59.22M |
| 254 | CCCC | C4 Therapeutics, Inc. | 383.22M | 4.53% | 2,775,890 | 35.04M |
| 255 | VTVT | vTv Therapeutics Inc. | 379.20M | 1.03% | 111,860 | 36.84M |
| 256 | IKT | Inhibikase Therapeutics, Inc. | 373.25M | -0.49% | 765,110 | 1.00 |
| 257 | ENTA | Enanta Pharmaceuticals, Inc. | 367.42M | 6.19% | 348,991 | 65.26M |
| 258 | OBIO | Orchestra BioMed Holdings, Inc. | 354.02M | -1.01% | 177,320 | 31.98M |
| 259 | BNTC | Benitec Biopharma Inc. | 349.52M | 4.48% | 152,768 | - |
| 260 | OCGN | Ocugen, Inc. | 349.28M | 0.98% | 4,456,118 | 4.58M |
| 261 | SRZN | Surrozen, Inc. | 348.38M | 0.34% | 409,591 | 11.51M |
| 262 | ARTV | Artiva Biotherapeutics, Inc. | 344.68M | 0.86% | 437,516 | 251.00K |
| 263 | CABA | Cabaletta Bio, Inc. | 339.09M | -3.38% | 5,436,382 | - |
| 264 | LRMR | Larimar Therapeutics, Inc. | 330.89M | 3.09% | 1,666,262 | - |
| 265 | VOGX | Vogenx, Inc. | 326.81M | -3.21% | 136,094 | - |
| 266 | VNDA | Vanda Pharmaceuticals Inc. | 312.59M | 2.38% | 545,155 | 215.72M |
| 267 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 305.46M | -3.54% | 476,591 | - |
| 268 | EVMN | Evommune, Inc. | 304.49M | -1.18% | 660,747 | 10.00M |
| 269 | ABEO | Abeona Therapeutics Inc. | 302.50M | -2.04% | 872,868 | 25.52M |
| 270 | IPSC | Century Therapeutics, Inc. | 302.40M | - | 408,899 | 109.16M |
| 271 | XFOR | X4 Pharmaceuticals, Inc. | 298.93M | 0.17% | 838,318 | 15.85M |
| 272 | SABS | SAB Biotherapeutics, Inc. | 292.52M | -2.28% | 697,891 | 114.70K |
| 273 | UPB | Upstream Bio, Inc. | 290.29M | -1.12% | 615,400 | 3.16M |
| 274 | CUVL | Clinuvel Pharmaceuticals Limited | 289.14M | 2.13% | 8,705 | 65.05M |
| 275 | RCKT | Rocket Pharmaceuticals, Inc. | 286.51M | 0.58% | 2,072,841 | - |
| 276 | EYPT | EyePoint, Inc. | 285.36M | -8.56% | 3,282,404 | 2.79M |
| 277 | FATE | Fate Therapeutics, Inc. | 285.17M | 1.28% | 1,144,649 | 6.49M |
| 278 | FULC | Fulcrum Therapeutics, Inc. | 283.83M | -0.53% | 901,246 | 80.00M |
| 279 | IVVD | Invivyd, Inc. | 280.02M | 1.69% | 6,875,457 | 58.37M |
| 280 | QTTB | Q32 Bio Inc. | 274.77M | 5.25% | 991,972 | 53.74M |
| 281 | GLSI | Greenwich LifeSciences, Inc. | 272.87M | 2.03% | 82,920 | - |
| 282 | IMRX | Immuneering Corporation | 269.14M | -2.58% | 597,905 | - |
| 283 | IFRX | InflaRx N.V. | 268.21M | -3.70% | 426,386 | -11.54K |
| 284 | VCRE | Vicore Pharma Holding AB (publ) | 268.02M | -0.62% | 27,510 | 412.09K |
| 285 | STRO | Sutro Biopharma, Inc. | 265.80M | 0.31% | 165,702 | 45.70M |
| 286 | PALI | Palisade Bio, Inc. | 261.41M | 3.45% | 8,679,160 | 500.00K |
| 287 | BCYC | Bicycle Therapeutics plc | 259.67M | 0.68% | 442,524 | 61.21M |
| 288 | ACIU | AC Immune SA | 259.50M | 3.57% | 188,849 | 21.67M |
| 289 | MGNX | MacroGenics, Inc. | 258.62M | 8.56% | 1,911,917 | 175.14M |
| 290 | LXEO | Lexeo Therapeutics, Inc. | 257.61M | -5.14% | 1,254,761 | - |
| 291 | ZNTL | Zentalis Pharmaceuticals, Inc. | 246.15M | -3.70% | 1,273,576 | 26.87M |
| 292 | LCTX | Lineage Cell Therapeutics, Inc. | 245.57M | -5.73% | 1,573,857 | 13.08M |
| 293 | PYXS | Pyxis Oncology, Inc. | 241.88M | 1.40% | 368,269 | 11.04M |
| 294 | CAMP | Camp4 Therapeutics Corporation | 241.60M | -1.79% | 116,912 | 4.22M |
| 295 | LYEL | Lyell Immunopharma, Inc. | 238.68M | -1.12% | 128,176 | 27.00K |
| 296 | PRQR | ProQR Therapeutics N.V. | 232.85M | - | 471,629 | 21.05M |
| 297 | SION | Sionna Therapeutics, Inc. | 231.49M | -2.10% | 669,983 | - |
| 298 | SLGL | Sol-Gel Technologies Ltd. | 227.38M | 3.89% | 57,952 | 1.80M |
| 299 | TRDA | Entrada Therapeutics, Inc. | 224.27M | 0.97% | 442,585 | 4.69M |
| 300 | KROS | Keros Therapeutics, Inc. | 223.65M | -2.93% | 208,640 | 15.01M |
| 301 | YARW | Yarrow Bioscience, Inc. | 221.63M | -6.73% | 107,656 | - |
| 302 | CGEN | Compugen Ltd. | 220.71M | -2.10% | 92,156 | 74.00M |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 218.14M | -2.70% | 98,126 | 1.48M |
| 304 | AVXL | Anavex Life Sciences Corp. | 217.84M | -1.26% | 522,506 | - |
| 305 | PLX | Protalix BioTherapeutics, Inc. | 216.74M | -1.10% | 831,789 | 80.62M |
| 306 | ADAG | Adagene Inc. | 214.86M | 9.22% | 525,985 | 9.29M |
| 307 | ELDN | Eledon Pharmaceuticals, Inc. | 214.74M | -0.38% | 712,919 | - |
| 308 | ALEC | Alector, Inc. | 214.38M | -1.54% | 713,340 | 13.86M |
| 309 | WHWK | Whitehawk Therapeutics, Inc. | 214.35M | 0.53% | 277,922 | 7.15M |
| 310 | CNTN | Canton Strategic Holdings, Inc. | 214.34M | 4.67% | 1,166,274 | 1.50M |
| 311 | FHTX | Foghorn Therapeutics Inc. | 209.04M | 0.57% | 283,795 | 36.74M |
| 312 | NGEN | NervGen Pharma Corp. | 202.14M | -3.09% | 524,928 | - |
| 313 | CMPX | Compass Therapeutics, Inc. | 199.90M | -1.77% | 2,761,801 | 850.00K |
| 314 | CUE | Cue Biopharma, Inc. | 199.41M | -12.61% | 237,438 | 37.66M |
| 315 | ORMP | Oramed Pharmaceuticals Inc. | 197.59M | 0.42% | 110,378 | 2.00M |
| 316 | VRXA | Veraxa Biotech AG | 193.73M | -2.84% | 48,479 | 29.54K |
| 317 | ALXO | ALX Oncology Holdings Inc. | 192.21M | 6.11% | 1,958,727 | - |
| 318 | TARA | Protara Therapeutics, Inc. | 192.06M | -0.91% | 431,133 | - |
| 319 | NKTX | Nkarta, Inc. | 191.24M | -2.91% | 810,182 | - |
| 320 | ANTX | AN2 Therapeutics, Inc. | 189.06M | 2.66% | 318,455 | - |
| 321 | MSLE | Satellos Bioscience Inc. | 186.53M | 1.26% | 47,167 | - |
| 322 | ACOG | Alpha Cognition Inc. | 185.66M | 0.65% | 67,113 | 15.26M |
| 323 | MDWD | MediWound Ltd. | 179.84M | 0.65% | 56,498 | 11.86M |
| 324 | PEPG | PepGen Inc. | 178.69M | -0.39% | 740,049 | - |
| 325 | CHRS | Coherus Oncology, Inc. | 176.13M | 0.88% | 1,142,540 | 50.94M |
| 326 | DTIL | Precision BioSciences, Inc. | 172.23M | 0.32% | 222,239 | 45.06M |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 169.80M | 0.41% | 342,210 | 29.10M |
| 328 | VYGR | Voyager Therapeutics, Inc. | 166.37M | 0.75% | 646,060 | 34.46M |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 166.33M | 2.68% | 856,253 | - |
| 330 | NERV | Minerva Neurosciences, Inc. | 162.34M | - | 62,104 | - |
| 331 | NBP | NovaBridge Biosciences | 157.76M | -1.45% | 367,106 | - |
| 332 | HUMA | Humacyte, Inc. | 152.01M | -1.81% | 4,888,885 | 2.12M |
| 333 | MOLN | Molecular Partners AG | 151.99M | -10.23% | 2,256 | 856.30K |
| 334 | IPHA | Innate Pharma S.A. | 151.28M | - | 42,059 | 11.21M |
| 335 | OTLK | Outlook Therapeutics, Inc. | 151.21M | -2.88% | 5,995,783 | -1.16M |
| 336 | CDXS | Codexis, Inc. | 148.93M | 3.03% | 698,879 | 77.68M |
| 337 | MENS | Jyong Biotech Ltd. | 146.24M | -2.96% | 46,411 | - |
| 338 | RNA | Atrium Therapeutics, Inc. | 144.03M | 1.57% | 504,912 | 35.84M |
| 339 | NAUT | Nautilus Biotechnology, Inc. | 141.25M | 15.30% | 3,929,530 | 190.00K |
| 340 | ARMP | Armata Pharmaceuticals, Inc. | 140.55M | 1.07% | 85,596 | 5.54M |
| 341 | KRRO | Korro Bio, Inc. | 140.04M | -0.63% | 132,312 | 2.38M |
| 342 | SPRB | Spruce Biosciences, Inc. | 136.54M | -2.48% | 42,337 | 697.00K |
| 343 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 133.84M | -3.08% | 931,188 | - |
| 344 | HURA | TuHURA Biosciences, Inc. | 133.19M | -0.48% | 375,383 | - |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 132.25M | -3.25% | 6,060,414 | 1.34M |
| 346 | ENGN | enGene Therapeutics Inc. | 132.02M | 0.51% | 331,985 | - |
| 347 | CRBU | Caribou Biosciences, Inc. | 131.87M | -0.81% | 810,406 | 10.04M |
| 348 | KZIA | Kazia Therapeutics Limited | 131.56M | 0.31% | 285,468 | 1.27M |
| 349 | NMRA | Neumora Therapeutics, Inc. | 129.99M | 2.10% | 3,308,277 | - |
| 350 | IMUX | Immunic, Inc. | 129.76M | 1.77% | 646,844 | - |
| 351 | UNCY | Unicycive Therapeutics, Inc. | 129.25M | -1.17% | 601,473 | - |
| 352 | TLSA | Tiziana Life Sciences Ltd | 126.79M | -2.92% | 389,011 | - |
| 353 | LENZ | LENZ Therapeutics, Inc. | 124.42M | 1.15% | 711,795 | 21.48M |
| 354 | NRXP | NRx Pharmaceuticals, Inc. | 124.16M | -4.17% | 731,629 | 3.39M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 120.98M | -0.85% | 1,837,089 | 65.34K |
| 356 | COYA | Coya Therapeutics, Inc. | 116.82M | -1.97% | 119,931 | 8.02M |
| 357 | AARD | Aardvark Therapeutics, Inc. | 115.33M | 4.15% | 60,648 | - |
| 358 | VANI | Vivani Medical, Inc. | 113.66M | 1.61% | 106,986 | - |
| 359 | SEER | Seer, Inc. | 112.41M | 6.28% | 699,064 | 14.22M |
| 360 | CBUS | Cibus, Inc. | 112.35M | -3.29% | 103,044 | 4.35M |
| 361 | MIST | Milestone Pharmaceuticals Inc. | 112.08M | 0.89% | 418,219 | 2.34M |
| 362 | OKUR | OnKure Therapeutics, Inc. | 111.77M | -4.83% | 441,326 | - |
| 363 | GNLX | Genelux Corporation | 110.69M | -0.40% | 98,927 | 8.00K |
| 364 | RANI | Rani Therapeutics Holdings, Inc. | 108.17M | 2.21% | 617,069 | 4.88M |
| 365 | PYPD | PolyPid Ltd. | 107.86M | 1.72% | 74,880 | - |
| 366 | EQ | Equillium, Inc. | 106.53M | 0.60% | 236,785 | 4.39M |
| 367 | TVGN | Tevogen Inc. | 106.38M | -6.76% | 15,625 | - |
| 368 | CNXU | Conexeu Sciences Inc. | 106.34M | -3.08% | 179,458 | - |
| 369 | TENX | Tenax Therapeutics, Inc. | 105.97M | 2.21% | 2,207,741 | - |
| 370 | CLLS | Cellectis S.A. | 105.72M | 0.68% | 58,045 | 63.82M |
| 371 | BDTX | Black Diamond Therapeutics, Inc. | 105.14M | -2.66% | 648,280 | 70.00M |
| 372 | MNOV | MediciNova, Inc. | 103.36M | -18.60% | 1,617,437 | 920.48K |
| 373 | PMVP | PMV Pharmaceuticals, Inc. | 102.70M | 2.26% | 336,102 | - |
| 374 | PLYX | Polaryx Therapeutics, Inc. | 101.69M | -2.39% | 16,455 | - |
| 375 | NTRB | Nutriband Inc. | 100.04M | 2.88% | 279,759 | 1.62M |
| 376 | ANIX | Anixa Biosciences, Inc. | 96.99M | 0.36% | 305,511 | - |
| 377 | PMN | ProMIS Neurosciences, Inc. | 95.51M | -5.50% | 25,055 | - |
| 378 | BMEA | Biomea Fusion, Inc. | 93.50M | -2.27% | 1,444,306 | - |
| 379 | CRDF | Cardiff Oncology, Inc. | 93.35M | -3.23% | 360,253 | 508.00K |
| 380 | NRXS | NeurAxis, Inc. | 92.93M | -2.12% | 63,850 | 5.32M |
| 381 | ICCC | ImmuCell Corporation | 89.73M | -0.45% | 4,451 | 30.68M |
| 382 | RLYB | Rallybio Corporation | 89.38M | 1.26% | 16,069 | 646.00K |
| 383 | CGTX | Cognition Therapeutics, Inc. | 89.24M | 0.20% | 200,193 | - |
| 384 | ACRV | Acrivon Therapeutics, Inc. | 88.28M | -1.90% | 230,990 | - |
| 385 | ONCY | Oncolytics Biotech Inc. | 84.54M | -2.97% | 1,127,637 | - |
| 386 | ATRA | Atara Biotherapeutics, Inc. | 84.02M | -4.99% | 23,524 | 6.19M |
| 387 | TELO | Telomir Pharmaceuticals, Inc. | 82.53M | -2.44% | 72,092 | - |
| 388 | PTHS | Pelthos Therapeutics Inc. | 81.35M | -4.24% | 12,006 | 43.30M |
| 389 | VRCA | Verrica Pharmaceuticals Inc. | 79.02M | 5.26% | 32,964 | 30.32M |
| 390 | NTHI | NeOnc Technologies Holdings, Inc. | 78.55M | -4.53% | 108,469 | 39.99K |
| 391 | GANX | Gain Therapeutics, Inc. | 77.25M | -0.56% | 547,104 | - |
| 392 | OSTX | OS Therapies Incorporated | 76.11M | -0.60% | 353,047 | - |
| 393 | IBIO | iBio, Inc. | 75.24M | -1.68% | 290,607 | 100.00K |
| 394 | GUTS | Fractyl Health, Inc. | 74.97M | -3.01% | 1,393,432 | 3.00K |
| 395 | BSEM | BioStem Technologies, Inc. | 72.83M | -1.45% | 181,695 | 34.59M |
| 396 | FBIO | Fortress Biotech, Inc. | 72.37M | -4.82% | 262,757 | 68.47M |
| 397 | OKYO | OKYO Pharma Limited | 71.90M | -0.72% | 138,070 | - |
| 398 | MAIA | MAIA Biotechnology, Inc. | 71.77M | -1.67% | 985,423 | - |
| 399 | GOSS | Gossamer Bio, Inc. | 70.39M | 5.30% | 516,264 | 53.29M |
| 400 | CING | Cingulate Inc. | 70.09M | -0.21% | 171,791 | - |
| 401 | ALDX | Aldeyra Therapeutics, Inc. | 69.98M | -3.73% | 943,198 | - |
| 402 | RNXT | RenovoRx, Inc. | 69.95M | -6.63% | 876,676 | 1.98M |
| 403 | SPRO | Spero Therapeutics, Inc. | 69.30M | -3.25% | 393,010 | 47.00M |
| 404 | CSBR | Champions Oncology, Inc. | 68.62M | 0.61% | 4,353 | 60.66M |
| 405 | ACET | Adicet Bio, Inc. | 68.35M | -29.60% | 2,139,524 | - |
| 406 | CNTB | Connect Biopharma Holdings Limited | 68.01M | - | 959,827 | 2.95M |
| 407 | KLRS | Kalaris Therapeutics, Inc. | 67.73M | -2.57% | 92,778 | - |
| 408 | PLRX | Pliant Therapeutics, Inc. | 66.88M | - | 349,130 | - |
| 409 | ALPS | Alps Group Inc | 66.56M | 1.01% | 117,994 | 3.74M |
| 410 | XBIT | XBiotech Inc. | 66.01M | -0.23% | 41,687 | - |
| 411 | HYFT | MindWalk Holdings Corp. | 63.13M | -2.90% | 64,002 | 11.57M |
| 412 | RNTX | Rein Therapeutics Inc. | 62.20M | -3.66% | 162,787 | - |
| 413 | ATHE | Alterity Therapeutics Limited | 62.00M | -4.63% | 10,413 | 2.50M |
| 414 | INKT | MiNK Therapeutics, Inc. | 61.80M | -0.57% | 13,742 | - |
| 415 | HYPD | Hyperion DeFi, Inc. | 60.84M | -3.09% | 741,912 | 1.40M |
| 416 | ELOX | Eloxx Pharmaceuticals, Inc. | 60.55M | -0.20% | 16,408 | - |
| 417 | XLO | Xilio Therapeutics, Inc. | 59.55M | 0.11% | 11,112 | 64.09M |
| 418 | BOLD | Boundless Bio, Inc. | 59.37M | -1.88% | 142,236 | - |
| 419 | MREO | Mereo BioPharma Group plc | 59.09M | - | 1,707,054 | 500.00K |
| 420 | ANVS | Annovis Bio, Inc. | 58.80M | 5.34% | 1,163,340 | - |
| 421 | CLNN | Clene Inc. | 57.71M | -5.58% | 91,618 | 197.00K |
| 422 | EXOZ | eXoZymes, Inc. | 55.69M | -3.92% | 8,281 | -700.00 |
| 423 | INMB | INmune Bio Inc. | 55.51M | -1.48% | 191,597 | 50.00K |
| 424 | HRTX | Heron Therapeutics, Inc. | 55.40M | -0.82% | 1,124,448 | 151.18M |
| 425 | IMA | ImageneBio, Inc. | 52.67M | -1.69% | 2,192 | 800.00K |
| 426 | APLM | Apollomics, Inc. | 52.36M | 6.69% | 2,338 | 8.84M |
| 427 | SER | Serina Therapeutics, Inc. | 51.05M | -3.83% | 1,016,535 | 130.00K |
| 428 | EDSA | Edesa Biotech, Inc. | 49.32M | -8.98% | 48,109 | - |
| 429 | ELTX | Elicio Therapeutics, Inc. | 48.62M | 0.54% | 220,793 | - |
| 430 | IBO | Impact BioMedical Inc. | 47.93M | -1.41% | 6,773 | 35.00K |
| 431 | TIL | Instil Bio, Inc. | 47.75M | -1.81% | 11,567 | - |
| 432 | LITS | Lite Strategy, Inc. | 46.27M | -5.56% | 950,663 | - |
| 433 | DWTX | Dogwood Therapeutics, Inc. | 46.23M | - | 82,068 | - |
| 434 | BYSI | BeyondSpring Inc. | 46.05M | 44.11% | 8,113,683 | 1.88M |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 45.23M | -3.05% | 699,247 | 21.00M |
| 436 | GRCE | Grace Therapeutics, Inc. | 44.60M | - | 58,723 | - |
| 437 | MGX | Metagenomi Therapeutics, Inc. | 43.25M | -0.43% | 131,999 | 13.56M |
| 438 | VERU | Veru Inc. | 43.05M | -0.59% | 101,292 | 16.89M |
| 439 | PDSB | PDS Biotechnology Corporation | 42.87M | -3.91% | 3,984,709 | - |
| 440 | FLNA | Filana Therapeutics, Inc. | 41.22M | 14.05% | 2,053,942 | - |
| 441 | CELU | Celularity Inc. | 40.52M | 1.45% | 112,163 | 26.55M |
| 442 | CRVO | CervoMed Inc. | 40.37M | 5.12% | 159,959 | 331.30K |
| 443 | BCTX | BriaCell Therapeutics Corp. | 37.17M | -3.71% | 293,435 | - |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 37.10M | -1.67% | 75,355 | 35.09M |
| 445 | KPTI | Karyopharm Therapeutics Inc. | 36.74M | - | 326,527 | 146.62M |
| 446 | IMMP | Immutep Limited | 35.19M | -7.40% | 49,122 | 13.79M |
| 447 | MCRB | Seres Therapeutics, Inc. | 34.99M | - | 55,460 | 1.88M |
| 448 | ALGS | Aligos Therapeutics, Inc. | 34.59M | 0.54% | 79,511 | 31.52M |
| 449 | NNVC | NanoViricides, Inc. | 34.17M | 4.17% | 632,727 | - |
| 450 | QNTM | Quantum BioPharma Ltd. | 32.03M | 2.86% | 139,764 | - |
| 451 | CNTX | Context Therapeutics Inc. | 29.98M | -5.61% | 1,493,227 | - |
| 452 | CVM | CEL-SCI Corporation | 29.90M | 1.80% | 126,172 | - |
| 453 | QNCX | Quince Therapeutics, Inc. | 29.50M | -6.42% | 40,768 | - |
| 454 | ATYR | aTyr Pharma, Inc. | 29.20M | -2.39% | 4,052,226 | 190.00K |
| 455 | RNAZ | TransCode Therapeutics, Inc. | 28.95M | 1.18% | 40,437 | - |
| 456 | IGC | IGC Pharma, Inc. | 28.33M | -2.97% | 1,071,432 | 1.11M |
| 457 | KYNB | Kyntra Bio, Inc. | 27.94M | -0.58% | 12,218 | 4.62M |
| 458 | ABVC | ABVC BioPharma, Inc. | 27.22M | -7.08% | 73,848 | 797.92K |
| 459 | LONA | LeonaBio, Inc. | 27.04M | -11.69% | 947,692 | - |
| 460 | EVAX | Evaxion A/S | 27.02M | -2.99% | 55,693 | 7.49M |
| 461 | QNRX | Quoin Pharmaceuticals, Ltd. | 25.27M | -18.20% | 70,148 | - |
| 462 | PLRZ | Polyrizon Ltd. | 24.89M | -3.85% | 4,466 | - |
| 463 | GRDX | GridAI Technologies Corp. | 24.57M | 1.17% | 36,387 | - |
| 464 | COCP | Cocrystal Pharma, Inc. | 23.50M | 4.27% | 32,115 | 330.00K |
| 465 | NXTC | NextCure, Inc. | 23.25M | - | 63,171 | - |
| 466 | TCRX | TScan Therapeutics, Inc. | 23.04M | - | 359,162 | 7.11M |
| 467 | PBM | Psyence Biomedical Ltd. | 21.61M | 1.89% | 48,312 | - |
| 468 | RADX | Radiopharm Theranostics Limited | 21.32M | -7.88% | 43,967 | 9.34M |
| 469 | JSPR | Jasper Therapeutics, Inc. | 20.83M | 2.77% | 251,125 | - |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 19.81M | 0.27% | 2,877 | 1.17M |
| 471 | ATOS | Atossa Therapeutics, Inc. | 19.56M | 3.16% | 152,908 | - |
| 472 | AKTX | Akari Therapeutics, Plc | 19.10M | 0.56% | 82,006 | - |
| 473 | ESLA | Estrella Immunopharma, Inc. | 18.76M | -10.31% | 35,920 | - |
| 474 | MRKR | Marker Therapeutics, Inc. | 18.51M | -3.48% | 164,332 | 3.55M |
| 475 | TVRD | Tvardi Therapeutics, Inc. | 17.74M | 4.72% | 351,242 | - |
| 476 | ACTU | Actuate Therapeutics, Inc. | 17.68M | 8.26% | 276,927 | - |
| 477 | CLRB | Cellectar Biosciences, Inc. | 17.30M | 1.67% | 58,905 | - |
| 478 | LPCN | Lipocine Inc. | 17.23M | -0.48% | 34,393 | 1.57M |
| 479 | KPRX | Kiora Pharmaceuticals, Inc. | 16.99M | 1.52% | 6,674 | 20.00K |
| 480 | DYAI | Dyadic International, Inc. | 16.94M | 11.78% | 306,958 | 3.80M |
| 481 | NCEL | NewcelX Ltd. | 16.87M | -0.90% | 7,202 | - |
| 482 | PTN | Palatin Technologies, Inc. | 16.48M | -5.10% | 39,284 | 13.19M |
| 483 | KTTA | Pasithea Therapeutics Corp. | 16.04M | -3.85% | 151,160 | - |
| 484 | BCDA | BioCardia, Inc. | 15.74M | -0.95% | 159,195 | 3.00K |
| 485 | ALLR | Allarity Therapeutics, Inc. | 15.41M | -5.98% | 270,906 | 345.00K |
| 486 | CNSY | Cerenome, Inc. | 15.33M | 1.51% | 97,846 | 4.20M |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 15.07M | -5.12% | 279,392 | 7.11M |
| 488 | PASG | Passage Bio, Inc. | 15.04M | -2.60% | 18,645 | - |
| 489 | ICU | SeaStar Medical Holding Corporation | 14.98M | -0.58% | 10,433 | 1.71M |
| 490 | HIND | Vyome Holdings, Inc. | 14.25M | -0.49% | 5,133 | 129.73K |
| 491 | LTRN | Lantern Pharma Inc. | 13.93M | -10.66% | 454,317 | - |
| 492 | NIKI | Niki BioSolutions, Inc. | 13.81M | -1.26% | 21,888 | - |
| 493 | TPST | Tempest Therapeutics, Inc. | 13.75M | 0.31% | 256,396 | - |
| 494 | LSTA | Lisata Therapeutics, Inc. | 13.53M | -4.94% | 38,129 | 100.00K |
| 495 | VTGN | Vistagen Therapeutics, Inc. | 13.18M | 8.79% | 6,037,127 | 2.50M |
| 496 | AEON | AEON Biopharma, Inc. | 13.05M | -0.76% | 310,631 | - |
| 497 | GTBP | GT Biopharma, Inc. | 12.27M | -1.31% | 34,845 | - |
| 498 | INAB | IN8bio, Inc. | 12.22M | 3.33% | 73,916 | - |
| 499 | PLUR | Pluri Inc. | 11.98M | -3.96% | 16,659 | 1.02M |
| 500 | INTS | Intensity Therapeutics, Inc. | 11.92M | -3.95% | 36,122 | - |